Elicio Therapeutics, Inc. (ELTX)
Nasdaq: ELTX · Pharmaceutical Preparations · Boston, MA · filing with the SEC since 2014
Who owns Elicio Therapeutics, Inc.
As filed with the SECHolders of 5% or more
4
Yekaterina Chudnovsky holds 48.1% of Common Stock, par value $0.01 per share, as its SCHEDULE 13D/A filed Mar 7, 2025 says.
Directors and officers
11
report now, of 20 people on the record since 2021. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 4 named at left.
Holders of 5% or moreshare of the class, as filed
Yekaterina Chudnovsky
SCHEDULE 13D/A · filed Mar 7, 2025 · Common Stock, par value $0.01 per share
Gkcc, LLC
SCHEDULE 13D/A · filed Jun 4, 2025 · Common Stock, par value $0.01 per share
Moti Investments LLC
SCHEDULE 13G · filed Jul 16, 2026 · Common Stock, par value $0.01 per share
Knoll Capital Management, LLC
SCHEDULE 13G/A · filed Jul 8, 2026 · Common Stock, par value $0.01 per share · 5.2% in Feb 5, 2025
Actyus Private Equity SGIIC, S.A.
SCHEDULE 13G/A · filed Oct 7, 2025 · Common Stock, par value $0.01 per share · reported falling below 5%, from 5.4% in May 14, 2025
What ELTX reports owning in othersstakes of 5% or more, and other ties
3 subsidiaries in 2 countries, from the list filed with the 10-K filed Mar 31, 2025.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2022 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.